A meta-analysis assessing objective response rates with first-line systemic treatment options in locally advanced/metastatic urothelial carcinoma

被引：0
|
作者：
Saxena, Akshat
Naqvi, Syed Arsalan Ahmed
Tripathi, Nikita
Khan, Muhammad Ali
Bibi, Arifa
Ballouz, Tara
Abdul-Muhsin, Haidar
Tyson, Mark
Bin Riaz, Irbaz
Bryce, Alan Haruo
Singh, Parminder
机构：
[1] Mayo Clin, Div Hematol & Med Oncol, Scottsdale, AZ USA
[2] Mayo Clin, Div Hematol & Med Oncol, Phoenix, AZ USA
[3] Mayo Clin, Div Hematol & Oncol, Phoenix, AZ USA
[4] Mayo Clin, Dept Internal Med, Scottsdale, AZ USA
[5] Mayo Clin Arizona, Phoenix, AZ USA
[6] Mayo Clin, Div Hematol & Oncol, Scottsdale, AZ USA
[7] Mayo Clin Arizona, Scottsdale, AZ USA
[8] Mayo Clin, Phoenix, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.4_suppl.639
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：639 / 639
页数：1
相关论文
共 50 条
  • [1] Network meta-analysis of first-line systemic therapies for advanced hepatocellular carcinoma: A comparison of objective response rates
    Kaur, G.
    Singh, B.
    Attri, S.
    Sharma, A.
    Rai, P.
    Pandey, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S616 - S616
  • [2] Systematic literature review and network meta-analysis of first-line therapies for locally advanced/metastatic urothelial carcinoma
    Bloudek, Lisa
    Huang, Shirley
    Wright, Phoebe
    Shih, Vanessa
    Dillon, Ryan
    Martirosyan, Anna
    Pandey, Rajshree
    Williams, Troy
    Chang, Nancy N.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Avelumab as First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial Carcinoma
    Mansinho, Andre
    Cruz, Andreia
    Marconi, Lorenzo
    Pinto, Cidalia
    Augusto, Isabel
    ADVANCES IN THERAPY, 2023, 40 (10) : 4134 - 4150
  • [4] Avelumab as First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial Carcinoma
    André Mansinho
    Andreia Cruz
    Lorenzo Marconi
    Cidália Pinto
    Isabel Augusto
    Advances in Therapy, 2023, 40 : 4134 - 4150
  • [5] Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy
    Tassinari, Elisa
    Mollica, Veronica
    Nuvola, Giacomo
    Marchetti, Andrea
    Rosellini, Matteo
    Massari, Francesco
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1945 - 1960
  • [6] Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder
    E. El Rassy
    T. Assi
    Z. Bakouny
    N. Pavlidis
    J. Kattan
    Clinical and Translational Oncology, 2019, 21 : 280 - 288
  • [7] Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder
    El Rassy, E.
    Assi, T.
    Bakouny, Z.
    Pavlidis, N.
    Kattan, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (03): : 280 - 288
  • [8] Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding
    Apolo, Andrea B.
    Michaels-Igbokwe, Christine
    Simon, Nicholas I.
    Benjamin, David J.
    Farrar, Mallory
    Hepp, Zsolt
    Mucha, Lisa
    Heidenreich, Sebastian
    Cutts, Katelyn
    Krucien, Nicolas
    Ramachandran, Natasha
    Gore, John L.
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2025, 18 (01): : 77 - 87
  • [9] First-Line Therapy in locally advanced or metastatic Urothelial Cancer
    Rexer, H.
    ONKOLOGE, 2012, 18 (01): : 70 - 71
  • [10] First-Line Therapy in locally advanced or metastatic Urothelial Cancer
    Rexer, H.
    ONKOLOGE, 2011, 17 (07): : 638 - 639
12345